Neurocarrus Live: Final Phase Q&A with CEO Paul Blum
This is a final live session with Neurocarrus CEO Paul Blum as we move through the closing phase of the current raise.
Over the past weeks, we’ve covered:
why pain treatment continues to rely on opioids
limitations of current approaches
how a non-opioid strategy could differ
This session is an opportunity to ask questions directly and hear a clear summary of where things stand.
In this session, we’ll cover:
Key takeaways from prior discussions
The current development stage
What comes next in the near term
Open Q&A with CEO Paul Blum
This session will be more conversational and focused on addressing questions from attendees.
We’ll have time for live Q&A throughout.
Join us for a final live discussion and bring your questions.
This discussion is intended for informational purposes only.